Related Experiment Videos
[Photocoagulation given additional benefit by calciumdobesilate (author's transl)].
Klinische Monatsblatter Fur Augenheilkunde
|May 1, 1979
Summary
Calciumdobesilate enhances photocoagulation treatment for diabetic retinopathy. This study shows improved retinal alterations in patients with advanced diabetic retinopathy when treated with Calciumdobesilate alongside photocoagulation.
Area of Science:
- Ophthalmology
- Diabetology
- Pharmacology
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Advanced stages (III-IV) require effective treatment strategies.
- Photocoagulation is a standard treatment, but outcomes can be improved.
Purpose of the Study:
- To evaluate the efficacy of Calciumdobesilate as an adjunct therapy for diabetic retinopathy.
- To determine if Calciumdobesilate enhances the effects of photocoagulation.
Main Methods:
- 52 patients with diabetic retinopathy (stages III-IV) underwent bilateral photocoagulation.
- 26 of these patients received subsequent Calciumdobesilate treatment for 5-68 months.
Main Results:
- Calciumdobesilate significantly enhanced the positive effects of photocoagulation.
- Retinal alterations in diabetic patients showed marked improvement with the combined therapy.
Conclusions:
- Calciumdobesilate is an effective adjuvant therapy for advanced diabetic retinopathy.
- Combining Calciumdobesilate with photocoagulation offers superior outcomes for retinal health in diabetic patients.